SEC Form 4 · accession 0001209191-15-003808

ACORDA THERAPEUTICS INC · ACOR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Enrique J. Carrazana

Officer — Chief Medical Officer

Period of report

Jan 8, 2015

Accepted (ET)

Jan 12, 2015 · 9:33 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001008848

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jan 8, 2015	M	6,715	$30.46	A	40,209	D
Common Stock^F1,F2	Jan 8, 2015	S	6,715	$42.0058	D	33,494	D
Common Stock^F1	Jan 9, 2015	M	16,803	$30.46	A	50,297	D
Common Stock^F1	Jan 9, 2015	M	18,225	$26.35	A	68,522	D
Common Stock^F1	Jan 9, 2015	M	42,879	$21.52	A	111,401	D
Common Stock^F1,F3	Jan 9, 2015	S	77,907	$42.1058	D	33,494	D
Common Stock^F1	Jan 12, 2015	M	13,371	$21.52	A	46,865	D
Common Stock^F1,F4	Jan 12, 2015	S	8,200	$42.6097	D	38,665	D
Common Stock^F1,F5	Jan 12, 2015	S	5,171	$43.5045	D	33,494	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1,F6	$30.46	Jan 8, 2015	M	6,715	D	—	Mar 6, 2023	Common Stock	6,715	40,320	D
Employee Stock Option (right to buy)^F1,F6	$30.46	Jan 9, 2015	M	16,803	D	—	Mar 6, 2023	Common Stock	16,803	23,517	D
Employee Stock Option (right to buy)^F1,F7	$26.35	Jan 9, 2015	M	18,225	D	—	Mar 15, 2022	Common Stock	18,225	6,075	D
Employee Stock Option (right to buy)^F1,F8	$21.52	Jan 9, 2015	M	42,879	D	—	Oct 15, 2021	Common Stock	42,879	32,121	D
Employee Stock Option (right to buy)^F1,F8	$21.52	Jan 12, 2015	M	13,371	D	—	Oct 15, 2021	Common Stock	13,371	18,750	D

Explanation of responses

F1Exercise and sales pursuant to a 10b5-1 plan.
F2The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.13 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.31 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.16 to $43.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $43.23 to $43.80 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2013 with the first quarterly installment vested on April 1, 2013.
F7The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2012 with the first quarterly installment vested on April 1, 2012.
F825% of the shares subject to this option vested on October 15, 2012. The balance of the shares subject to this option vest in equal quarterly installments over the three years thereafter.